EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling

Kaushik Sunder iD

Restorative Neurology and Neuroscience · 2026-08 · 44 (3) · 289-310

DOI: 10.1177/09226028261436622 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Restorative Neurology and Neuroscience, online erschienen am 20.04.2026. Verfasst von Kaushik Sunder. Beteiligte Einrichtung: NYU Office of the Provost, New York University, New York, NY, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Disease Models, Animal. Die Arbeit nennt 137 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons and α-synuclein accumulation. Despite extensive research, there remains a shortage of effective disease-modifying medicines, which is due in part to the failure to translate molecular insights into clinically useful models and diagnostics.

Objectives

This review will summarize recent developments in the PD pathophysiology and diagnostic, therapeutic and experimental models and will focus on the newer in vivo , in vitro and bioengineered in vivo platforms.

Methods

Recent studies on animal models, patient-induced pluripotent stem cell (iPSC) systems, three-dimensional (3D) bioprinting, neuroimaging, and biomarker discovery have been critically examined to determine their translational potential and limitations.

Results

Traditional animal models are effective at replicating dopaminergic degradation but fall short of fully replicating progressive and systemic elements of Parkinson's disease. iPSC-derived neurons and 3D-bioprinted constructs are more genetically specific and cellularly complex, allowing for patient-relevant modeling and medication screening. Advances in imaging and molecular biomarkers aid in earlier detection; nevertheless, no cross-validation or platform standards has been established.

Conclusion

Combining cellular, molecular, and bioengineered models with clinical diagnostics has the potential to improve translational accuracy and accelerate the development of disease-modifying treatments. A cross-platform system is critical for improving the predictive validity of preclinical studies in Parkinson's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDisease Models, AnimalHumansAnimalsInduced Pluripotent Stem Cells

Stichwörter der Autor:innen

3D bioprintingParkinson's diseasedisease modelingin vitro modelingin vivo modelsinduced pluripotent stem cellsneurodegeneration

Autor:innen und Institutionen

  • NYU Office of the Provost, New York University, New York, NY, USA.

ORCID-Profile: Kaushik Sunder

Zitieren

APA

Sunder, K. (2026). Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling. Restorative Neurology and Neuroscience, 44(3), 289-310. https://doi.org/10.1177/09226028261436622

Vancouver

Sunder K. Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling. Restorative Neurology and Neuroscience. 2026;44(3):289-310. doi:10.1177/09226028261436622

BibTeX
@article{Sunder2026,
  author = {Sunder, Kaushik},
  title = {Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling},
  journal = {Restorative Neurology and Neuroscience},
  year = {2026},
  volume = {44},
  number = {3},
  pages = {289--310},
  doi = {10.1177/09226028261436622}
}
Kostenlos starten →